Carcinoembryonic antigen levels in the peritoneal cavity: Useful guide to peritoneal recurrence and prognosis for gastric cancer
- 1 January 1995
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 19 (1) , 133-137
- https://doi.org/10.1007/bf00316997
Abstract
At the time of laparotomy, peritoneal washings were collected from 155 gastric cancer patients and the levels in carcinoembryonic antigen (CEA) determined. The CEA levels in peritoneal washings were statistically independent of those in sera and could more reliably predict the presence of peritoneal metastasis than a cytologic study. Peritoneal recurrence was seen in 14 of 118 patients after curative operation. Of the 14 patients, 10 (71%) had elevated levels of CEA (100 ng/g protein) at surgery. Of these 10 cases, 2 of the tumors were classified as stage IB and 4 had no serosal invasion. Only one patient with peritoneal metastasis and a low CEA level was free from relapse more than 1 year after operation. Kaplan-Meier's analysis showed that a high CEA level in peritoneal washings was a predictor of poor prognosis in patients who underwent either curative or noncurative resection. A proportional hazards regression analysis showed that a high CEA level in peritoneal washings was statistically significant in terms of predicting a shorter interval until peritoneal recurrence (p=0.0002) and for survival (p=0.0001). The CEA level in peritoneal washings is therefore of value as an indicator of peritoneal recurrence and prognosis.Keywords
This publication has 12 references indexed in Scilit:
- Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992Cancer, 1993
- Results of Surgery on 6589 Gastric Cancer Patients and Immunochemosurgery as the Best Treatment of Advanced Gastric CancerAnnals of Surgery, 1992
- Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinomaCancer, 1992
- Adjuvant Chemotherapy for Gastric Cancer in Japan: Present Status and Suggestions for Rational Clinical TrialsJapanese Journal of Clinical Oncology, 1990
- A review: Intraperitoneal cisplatin in the management of patients with ovarian cancerGynecologic Oncology, 1990
- ‘Two-Route Chemotherapy’ Using Cisplatin and Its Neutralizing Agent, Sodium Thiosulfate, for Intraperitoneal CancerOncology, 1990
- Prognostic Factors in Gastric Cancer With Serosal InvasionArchives of Surgery, 1989
- Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors.1989
- The Most Important Prognostic Factors for Gastric Cancer Patients: A Study Using Univariate and Multivariate AnalysesScandinavian Journal of Gastroenterology, 1987
- Results of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrenceWorld Journal of Surgery, 1977